378 related articles for article (PubMed ID: 10778988)
21. Effect of oxovanadium(IV) complexes on nondiabetic and streptozotocin-diabetic rats.
Krosniak M; Zachwieja Z; Filipek B; Zygmunt M; Grybos R
Arch Pharm (Weinheim); 2001 Dec; 334(12):388-92. PubMed ID: 11852534
[TBL] [Abstract][Full Text] [Related]
22. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
Peacock AF; Habtemariam A; Moggach SA; Prescimone A; Parsons S; Sadler PJ
Inorg Chem; 2007 May; 46(10):4049-59. PubMed ID: 17441712
[TBL] [Abstract][Full Text] [Related]
23. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
[TBL] [Abstract][Full Text] [Related]
25. V(IV)O and Cu(II) complexation by ligands based on pyridine nitrogen donors.
Sanna D; Buglyó P; Tomaz AI; Costa Pessoa J; Borović S; Micera G; Garribba E
Dalton Trans; 2012 Nov; 41(41):12824-38. PubMed ID: 22975792
[TBL] [Abstract][Full Text] [Related]
26. Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage.
Silva PP; Guerra W; Silveira JN; Ferreira AM; Bortolotto T; Fischer FL; Terenzi H; Neves A; Pereira-Maia EC
Inorg Chem; 2011 Jul; 50(14):6414-24. PubMed ID: 21692452
[TBL] [Abstract][Full Text] [Related]
27. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
[TBL] [Abstract][Full Text] [Related]
28. Rhenium(IV) compounds inducing apoptosis in cancer cells.
Martínez-Lillo J; Mastropietro TF; Lappano R; Madeo A; Alberto ME; Russo N; Maggiolini M; De Munno G
Chem Commun (Camb); 2011 May; 47(18):5283-5. PubMed ID: 21448489
[TBL] [Abstract][Full Text] [Related]
29. Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity.
D'Cruz OJ; Uckun FM
Expert Opin Investig Drugs; 2002 Dec; 11(12):1829-36. PubMed ID: 12457442
[TBL] [Abstract][Full Text] [Related]
30. Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.
Lodyga-Chruscinska E; Sanna D; Garribba E; Micera G
Dalton Trans; 2008 Sep; (36):4903-16. PubMed ID: 18766223
[TBL] [Abstract][Full Text] [Related]
31. Dinuclear copper(II) complexes with {Cu2(mu-hydroxo)bis(mu-carboxylato)}+ cores and their reactions with sugar phosphate esters: A substrate binding model of fructose-1,6-bisphosphatase.
Kato M; Tanase T; Mikuriya M
Inorg Chem; 2006 Apr; 45(7):2925-41. PubMed ID: 16562948
[TBL] [Abstract][Full Text] [Related]
32. Influence of Primary Ligands (ODA, TDA) on Physicochemical and Biological Properties of Oxidovanadium (IV) Complexes with Bipy and Phen as Auxiliary Ligands.
Pranczk J; Tesmar A; Wyrzykowski D; Inkielewicz-Stępniak I; Jacewicz D; Chmurzyński L
Biol Trace Elem Res; 2016 Nov; 174(1):251-258. PubMed ID: 27048276
[TBL] [Abstract][Full Text] [Related]
33. Unsymmetrical oxovanadium complexes derived from salicylaldehyde and phenanthroline: synthesis, DNA interactions, and antitumor activities.
Liao X; Pan W; He R; Guo H; Ying P; Lu J
Chem Biol Drug Des; 2014 Mar; 83(3):367-78. PubMed ID: 24118856
[TBL] [Abstract][Full Text] [Related]
34. Heterocyclic organobismuth(III) induces apoptosis of human promyelocytic leukemic cells through activation of caspases and mitochondrial perturbation.
Iuchi K; Hatano Y; Yagura T
Biochem Pharmacol; 2008 Oct; 76(8):974-86. PubMed ID: 18760261
[TBL] [Abstract][Full Text] [Related]
35. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins.
Kostova I; Momekov G; Zaharieva M; Karaivanova M
Eur J Med Chem; 2005 Jun; 40(6):542-51. PubMed ID: 15922838
[TBL] [Abstract][Full Text] [Related]
37. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
[TBL] [Abstract][Full Text] [Related]
38. The cellular intake kinetics and acute biological effects of various oxovanadium species: a comparative study.
Reuland DJ; Cao ZX; Rosenhein L; Poehlein S; McCoy L; Turner J; Durham T; Ganguli S
Horm Metab Res; 1998 Jan; 30(1):29-33. PubMed ID: 9503035
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship of new trans-platinum(II) and (IV) complexes with cyclohexylamine. Interference with cell cycle progression and induction of cell death.
González-Vadillo AM; Alvarez-Valdés A; Moneo V; Blanco F; Díaz RG; Carnero A; Navarro-Ranninger C
J Inorg Biochem; 2007 Apr; 101(4):551-8. PubMed ID: 17257684
[TBL] [Abstract][Full Text] [Related]
40. Leishmanicidal activity of polysaccharides and their oxovanadium(IV/V) complexes.
do Amaral AE; Petkowicz CL; Mercê AL; Iacomini M; Martinez GR; Merlin Rocha ME; Cadena SM; Noleto GR
Eur J Med Chem; 2015 Jan; 90():732-41. PubMed ID: 25506811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
